These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 38751926)
1. Connecting the Dots: Exploring the Relationship between Optical Coherence Tomography and Manchanda R; Samanta R; Narayan ML; Kumar M; Tiwari A; Agarwal A; Bahurupi Y; Kumari S; Kumar N Ann Indian Acad Neurol; 2024; 27(2):188-195. PubMed ID: 38751926 [TBL] [Abstract][Full Text] [Related]
2. A phase 2, open-label, multi-center study to evaluate the efficacy and safety of Sun Y; Liu C; Chen Z; Li B; Lv Z; Lou J; Tang J; Wang Y; Zhang G; Liu X Ann Nucl Med; 2020 Jan; 34(1):31-37. PubMed ID: 31646428 [TBL] [Abstract][Full Text] [Related]
3. Sensitivity and specificity of 99mTc-TRODAT-1 SPECT imaging in differentiating patients with idiopathic Parkinson's disease from healthy subjects. Weng YH; Yen TC; Chen MC; Kao PF; Tzen KY; Chen RS; Wey SP; Ting G; Lu CS J Nucl Med; 2004 Mar; 45(3):393-401. PubMed ID: 15001678 [TBL] [Abstract][Full Text] [Related]
4. The association of spectral-domain optical coherence tomography determined ganglion cell complex parameters and disease severity in Parkinson's disease. Bayhan HA; Aslan Bayhan S; Tanık N; Gürdal C Curr Eye Res; 2014 Nov; 39(11):1117-22. PubMed ID: 24655112 [TBL] [Abstract][Full Text] [Related]
5. Dopamine Transporter maging with Tc-99m TRODAT-1 SPECT in Parkinson's isease and its orrelation with linical isease everity. Patel A; Simon S; M Elangoven I; Amalchandran J; S Jain A; S T Asia Ocean J Nucl Med Biol; 2019; 7(1):22-28. PubMed ID: 30705908 [TBL] [Abstract][Full Text] [Related]
6. Investigating the role of 99mTc-TRODAT-1 SPECT imaging in idiopathic Parkinson's disease. Geng Y; Shi GH; Jiang Y; Xu LX; Hu XY; Shao YQ J Zhejiang Univ Sci B; 2005 Jan; 6(1):22-7. PubMed ID: 15593387 [TBL] [Abstract][Full Text] [Related]
7. Correlative (99m)tc-labeled tropane derivative single photon emission computer tomography and clinical assessment in the staging of Parkinson disease. Shinto AS; Antony J; Kamaleshwaran K; Vijayan K; Selvan A; Korde A; Kameshwaran M; Samuel G World J Nucl Med; 2014 Sep; 13(3):178-83. PubMed ID: 25538489 [TBL] [Abstract][Full Text] [Related]
8. Use of Dongfang C; Xianzhi M; Cen L; Zhongke H Hell J Nucl Med; 2022; 25(3):247-252. PubMed ID: 36507880 [TBL] [Abstract][Full Text] [Related]
9. Comparison of 99mTc-TRODAT-1 SPECT and 18 F-AV-133 PET imaging in healthy controls and Parkinson's disease patients. Hsiao IT; Weng YH; Lin WY; Hsieh CJ; Wey SP; Yen TC; Kung MP; Lu CS; Lin KJ Nucl Med Biol; 2014 Apr; 41(4):322-9. PubMed ID: 24503330 [TBL] [Abstract][Full Text] [Related]
10. Correlation between Arena JE; Urrutia L; Falasco G; de Leon MP; Vazquez S; Rossi M; Merello M Radiol Bras; 2021; 54(4):232-237. PubMed ID: 34393289 [TBL] [Abstract][Full Text] [Related]
11. Crossover study of (99m)Tc-TRODAT-1 SPECT and (18)F-FDOPA PET in Parkinson's disease patients. Huang WS; Chiang YH; Lin JC; Chou YH; Cheng CY; Liu RS J Nucl Med; 2003 Jul; 44(7):999-1005. PubMed ID: 12843212 [TBL] [Abstract][Full Text] [Related]
12. 99mTc-TRODAT-1 imaging of multiple system atrophy. Lu CS; Weng YH; Chen MC; Chen RS; Tzen KY; Wey SP; Ting G; Chang HC; Yen TC J Nucl Med; 2004 Jan; 45(1):49-55. PubMed ID: 14734673 [TBL] [Abstract][Full Text] [Related]
13. Comparative Performance of 99mTc-TRODAT-1 SPECT/CT and 18F-FDOPA PET/CT Imaging in Patients With Parkinson's Disease, Parkinson-Plus Syndrome, and Essential Tremor. Sood A; Shukla J; Shree R; Vatsa R; Modi M; Mittal BR Clin Nucl Med; 2021 Feb; 46(2):95-102. PubMed ID: 33234920 [TBL] [Abstract][Full Text] [Related]
14. Brain TRODAT-SPECT Versus MRI Morphometry in Distinguishing Early Mild Parkinson's Disease from Other Extrapyramidal Syndromes. Hossein-Tehrani MR; Ghaedian T; Hooshmandi E; Kalhor L; Foroughi AA; Ostovan VR J Neuroimaging; 2020 Sep; 30(5):683-689. PubMed ID: 32557946 [TBL] [Abstract][Full Text] [Related]
15. Parkinson's disease and levodopa-induced dyskinesias: a quantitative analysis through Pitella FA; Alexandre-Santos L; de Lacerda KJCC; Trevisan AC; Kato M; Padovan-Neto FE; Tumas V; Wichert-Ana L Radiol Bras; 2024; 57():e20230082. PubMed ID: 39077067 [TBL] [Abstract][Full Text] [Related]
16. Development of a prediction formula of Parkinson disease severity by optical coherence tomography. Jiménez B; Ascaso FJ; Cristóbal JA; López del Val J Mov Disord; 2014 Jan; 29(1):68-74. PubMed ID: 24458320 [TBL] [Abstract][Full Text] [Related]
17. Evaluation of early-stage Parkinson's disease with 99mTc-TRODAT-1 imaging. Huang WS; Lin SZ; Lin JC; Wey SP; Ting G; Liu RS J Nucl Med; 2001 Sep; 42(9):1303-8. PubMed ID: 11535717 [TBL] [Abstract][Full Text] [Related]
18. Degree of dopaminergic degeneration measured by Lin L; Ye J; Zhang H; Han ZF; Zheng ZH Neural Regen Res; 2018 Jul; 13(7):1281-1287. PubMed ID: 30028339 [TBL] [Abstract][Full Text] [Related]
19. 99mTc-TRODAT-1 SPECT/CT imaging as a complementary biomarker in the diagnosis of parkinsonian syndromes. Mittal BR; Sood A; Shukla J; Vatsa R; Bhusari P; Shree R; Mehta S; Goyal M; Modi M Nucl Med Commun; 2018 Apr; 39(4):312-318. PubMed ID: 29381583 [TBL] [Abstract][Full Text] [Related]
20. Reproducibility of 99mTc-TRODAT-1 SPECT measurement of dopamine transporters in Parkinson's disease. Hwang WJ; Yao WJ; Wey SP; Ting G J Nucl Med; 2004 Feb; 45(2):207-13. PubMed ID: 14960637 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]